Applovin Stock Discussion

10baggerbamm : when you see insider selling it's not a reason to panic most of the time their stock is granted to them at a cost basis of zero number one number two they have pre-arranged sales once or twice a year and he saw this with Nvidia in June everybody panicked old Jensen must know there's going to be a problem he sells every year.. then you have the fact that the majority of time statistically the timing of insider cells 6 months later has nothing to do with the stock price because most of the time the stocks are higher than when they sell. the better indicator is when insiders buy and I don't mean they exercise an option with the cost basis is zero but they're actually going out into the open market and acquiring shares that's really a best indicator where the Insiders are buying above and beyond their stock options that they have. this stock is just freaking stupid I mean I've just watched it go parabolic from $60 straight up I'm like the idiot on the side line at this rate it's going to go to $1,000 in a year and I'll just be the person on the sidewalk looking inside of the restaurant where everybody's eating their caviar and I'm picking up scraps on the street corner.. that's the only problem that I have is how do you justify buying it here when I watched it go up and had the inkling to buy it and I didn't pull the trigger I didn't step up to the plate and even buy a few shares. the saying is stocks that set new highs continuously set new highs so it's the exact opposite of a falling knife they just keep trending higher because people buy the breakouts people buy new highs and it keeps setting further highs

BREEZUSCHRIST : If I hadn’t sold way back when

72623473 : No use, internal personnel will deliberately create various troubles! Such as fire, such as leaking, and so on... Then they bottom out! Full of routines...

Steven J : I bought  $Concentrix (CNXC.US)$ ,$Advanced Micro Devices (AMD.US)$  at these low levels. Sold my $Axcelis Technologies (ACLS.US)$ at 136. I like that one too. But here one of my favorite and is very undervalued $Certara (CERT.US)$ and unappreciated by wallstreet.
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. The pipeline of getting drugs approved keeps going up and Biosimulation should be beneficiary. Do your own Homework